Equivalent tumor detection for early and late FAPI-46 PET acquisition

Abstract

Positron emission tomography (PET) using small ligands of the fibroblast activation protein (FAP) was recently introduced. However, optimal uptake time has not been defined yet. Here, we systematically compare early (~\u200910 min p.i.) and late (~\u200960 min p.i.) FAPI-46 imaging in patients with various types of cancer. This is a retrospective single-institutional study. Imaging was performed at the Essen University Hospital, Germany. A total of 69 patients who underwent dual time-point imaging for either restaging (n\u2009=\u200952, 75%) or staging (n\u2009=\u200917, 25%) of cancer were included. Patients underwent PET with two acquisitions: early (mean 11 min, SD 4) and late (mean 66 min, SD 9). Mean injected activity was 148 MBq (SD 33). In total, 400 lesions were detected in 69 patients. Two of 400 (0.5%) lesions were only seen in early time-point imaging but not in late time-point imaging. On a per-patient level, there was no significant difference between SUVmax of hottest tumor lesions (Wilcoxon: P\u2009=\u20090.73). Organ uptake demonstrated significant early to late decrease in SUVmean (average ∆SUVmean: −\u20090.48, −\u20090.14, −\u20090.27 for gluteus, liver, and mediastinum, respectively; Wilcoxon: P\u2009<\u20090.001). On a per-lesion basis, a slight increase of SUVmax was observed (average ∆SUVmax: +\u20090.4, Wilcoxon: P\u2009=\u20090.03). In conclusion, early (~\u200910 min p.i.) versus late (~\u200960 min p.i.) FAPI-46 imaging resulted in equivalent lesion uptake and tumor detection. For improved feasibility and scan volume, we implement early FAPI-46 PET in future clinical and research protocols.